Jeff Yass’s Jasper Therapeutics JSPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-343
Closed -$4.33K – 14039
2026
Q2
$4.33K Buy
+343
New +$7.7K ﹤0.01% 13199
2026
Q1
– Sell
-343
Closed -$18.8K – 13643
2025
Q4
$18.8K Sell
343
-520
-60% -$31.3K ﹤0.01% 11975
2025
Q3
$61.6K Sell
863
-330
-28% -$30K ﹤0.01% 11793
2025
Q2
$199K Buy
+1,193
New +$176K ﹤0.01% 11214
2025
Q1
– Sell
-723
Closed -$464K – 12998
2024
Q4
$464K Sell
723
-1,680
-70% -$1.05M ﹤0.01% 8856
2024
Q3
$1.36M Buy
2,403
+1,313
+120% +$784K ﹤0.01% 6136
2024
Q2
$742K Buy
1,090
+627
+135% +$451K ﹤0.01% 7282
2024
Q1
$408K Buy
+463
New +$247K ﹤0.01% 8992
2023
Q2
– Sell
-38
Closed -$20.5K – 12642
2023
Q1
$20.5K Buy
+38
New +$21.1K ﹤0.01% 12044

Other funds holding JSPR

Jeff Yass's JSPR Position: Q3 2026 in Review

Jeff Yass opened a new position in Jasper Therapeutics (JSPR) in Q3 2026: 1,146 shares worth $19.9K. The stake represents ﹤0.01% of the portfolio and ranks #13126 among its holdings. This is a return to the name: Jeff Yass previously reported a position in JSPR as recently as Q1 2026.

Jeff Yass first reported a position in JSPR in Q4 2022 and has held it in 11 quarters since. The position peaked at $488K in Q4 2024. 50 funds tracked by Wall St. Rank hold JSPR as of Q3 2026.

  • Jeff Yass held 1,146 shares of Jasper Therapeutics worth $19.9K as of Q3 2026.
  • Jasper Therapeutics was a new Jeff Yass position in Q3 2026.
  • Jasper Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #13126 holding.
  • Jeff Yass first reported a position in Jasper Therapeutics in Q4 2022 and has held it in 11 quarters since.
  • Jeff Yass's Jasper Therapeutics position peaked at $488K in Q4 2024.
  • 50 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.